Chemical Compound
Hexadecanamide, N-[(1S,2R,3E)-1-[[[O-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl-(1 inverted exclamation marku3)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-|A-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
CAS Registry Number
11034-93-8
Primary record
Hexadecanamide, N-[(1S,2R,3E)-1-[[[O-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl-(1 inverted exclamation marku3)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-|A-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- 库存
- 2,937 克
- 纯度
- 98.3 %
- CAS
- 11034-93-8
化合物标识与属性
- CAS
- 11034-93-8
- PubChem CID
- 124202368
- SMILES
- CCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)NC(=O)C)O)O)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC
名称与同义词
- Gb4 Ceramide
- globoside
- GangliosideGL4
- Globotetraosylceramide
- RefChem:363084
- CHEBI:132968
- Tetrahexosylceramide (d18:1/16:0)
- G0580
- H27499
- A961050
- 11034-93-8
- 857895-26-2
- GalNAc-1->3-Gal-1->4-Gal-1->4-Glc-Cer (d18:1/16:0)
- GalNAcbeta1-3-Galalpha1-4Galbeta1-4Glcbeta1-1Cer (d18:1/16:0)
- N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
- N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide (d18:1/16:0)
- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer (d18:1/16:0)
- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(11')-Cer (d18:1/16:0)
- beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer (d18:1/16:0)
- beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(11')-Cer (d18:1/16:0)
- Hexadecanamide, N-[(1S,2R,3E)-1-[[[O-2-(acetylamino)-2-deoxy-|A-D-galactopyranosyl-(1 inverted exclamation marku3)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-O-|A-D-galactopyranosyl-(1 inverted exclamation marku4)-|A-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- N-((2S,3R,4E)-1-((2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl)oxy)-3-hydroxyoctadec-4-en-2-yl)hexadecanamide
- N-acetyl-|A-D-galactosaminyl-(1 inverted exclamation marku3)-|A-D-galactosyl-(1 inverted exclamation marku4)-|A-D-galactosyl-(1 inverted exclamation marku4)-|A-D-glucosylceramide
- N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-hexadecanoylsphing-4-enine
- N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(11')-N-hexadecanoylsphing-4-enine